Shakti Lifescience Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 01-11-2024
- Paid Up Capital ₹ 2.00 Cr
as on 01-11-2024
- Company Age 3 Year, 12 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 11.67 Cr
as on 01-11-2024
- Revenue 629.08%
(FY 2023)
- Profit 220.38%
(FY 2023)
- Ebitda 424.50%
(FY 2023)
- Net Worth 1944.28%
(FY 2023)
- Total Assets 22.58%
(FY 2023)
About Shakti Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.00 Cr.
The company currently has active open charges totaling ₹11.67 Cr.
Bhavin Shah, Babubhai Patel, Dahyabhai Patel, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24290MH2021PTC373066
- Company No.
373066
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
09 Dec 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shakti Lifescience?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bhavin Shah  | Director | 01-Apr-2023 | Current |
| Babubhai Patel | Director | 09-Dec-2021 | Current |
| Dahyabhai Patel | Director | 09-Dec-2021 | Current |
| Milind Patel | Director | 09-Dec-2021 | Current |
| Jignesh Amin | Director | 09-Dec-2021 | Current |
Financial Performance and Corporate Structure Insights of Shakti Lifescience.
Shakti Lifescience Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 629.08% increase. The company also saw a substantial improvement in profitability, with a 220.38% increase in profit. The company's net worth Soared by an impressive increase of 1944.28%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shakti Lifescience?
Unlock access to Shakti Lifescience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 09 Dec 2021 | ₹11.67 Cr | Open |
How Many Employees Work at Shakti Lifescience?
Shakti Lifescience has a workforce of 58 employees as of Mar 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shakti Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shakti Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
